| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Cannabinoid, CB1 | 31 | 2020 | 68 | 6.810 |
Why?
|
| Carrier Proteins | 9 | 2023 | 145 | 2.270 |
Why?
|
| Cannabinoids | 15 | 2023 | 56 | 2.000 |
Why?
|
| Endocannabinoids | 14 | 2023 | 44 | 1.720 |
Why?
|
| Receptors, Cannabinoid | 11 | 2011 | 33 | 1.590 |
Why?
|
| Signal Transduction | 21 | 2019 | 727 | 1.570 |
Why?
|
| Receptor, Cannabinoid, CB2 | 7 | 2020 | 23 | 1.210 |
Why?
|
| Fibroblasts | 3 | 2015 | 119 | 1.200 |
Why?
|
| Cyclic AMP | 5 | 2016 | 55 | 1.040 |
Why?
|
| Animals | 41 | 2017 | 8199 | 1.010 |
Why?
|
| GTP-Binding Proteins | 5 | 2016 | 40 | 0.950 |
Why?
|
| Arachidonic Acids | 8 | 2023 | 29 | 0.770 |
Why?
|
| Naphthalenes | 11 | 2016 | 53 | 0.770 |
Why?
|
| Neurons | 6 | 2019 | 486 | 0.740 |
Why?
|
| Receptors, Dopamine D2 | 6 | 2016 | 80 | 0.730 |
Why?
|
| Mice | 17 | 2017 | 2571 | 0.690 |
Why?
|
| Cell Line, Tumor | 10 | 2017 | 729 | 0.680 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 478 | 0.680 |
Why?
|
| Morpholines | 9 | 2016 | 47 | 0.670 |
Why?
|
| Gene Expression | 4 | 2013 | 346 | 0.620 |
Why?
|
| Phosphorylation | 9 | 2019 | 250 | 0.620 |
Why?
|
| Receptors, Drug | 4 | 2002 | 19 | 0.610 |
Why?
|
| Polyunsaturated Alkamides | 7 | 2023 | 13 | 0.570 |
Why?
|
| Piperidines | 9 | 2016 | 137 | 0.570 |
Why?
|
| Pyrazoles | 8 | 2016 | 77 | 0.570 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2017 | 35 | 0.550 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2017 | 1 | 0.530 |
Why?
|
| Nitric Oxide | 5 | 2014 | 121 | 0.530 |
Why?
|
| Antibodies | 1 | 2017 | 56 | 0.520 |
Why?
|
| Benzoxazines | 9 | 2016 | 28 | 0.500 |
Why?
|
| Baclofen | 2 | 2015 | 26 | 0.470 |
Why?
|
| Corpus Striatum | 3 | 2014 | 69 | 0.460 |
Why?
|
| Skin | 2 | 2014 | 212 | 0.450 |
Why?
|
| Cytokines | 2 | 2014 | 237 | 0.450 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 4 | 2014 | 8 | 0.450 |
Why?
|
| Receptors, GABA-B | 1 | 2015 | 19 | 0.440 |
Why?
|
| Neuropharmacology | 1 | 2014 | 3 | 0.440 |
Why?
|
| Humans | 33 | 2023 | 32282 | 0.430 |
Why?
|
| Brain | 4 | 2019 | 965 | 0.430 |
Why?
|
| Dermatitis | 1 | 2014 | 20 | 0.420 |
Why?
|
| Cell Movement | 1 | 2015 | 167 | 0.420 |
Why?
|
| Cell Line | 9 | 2016 | 454 | 0.420 |
Why?
|
| Plant Extracts | 1 | 2014 | 61 | 0.420 |
Why?
|
| Nicotinic Agonists | 1 | 2014 | 39 | 0.410 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 38 | 0.410 |
Why?
|
| Cyclohexanols | 6 | 2016 | 22 | 0.400 |
Why?
|
| Glycerides | 3 | 2015 | 14 | 0.400 |
Why?
|
| Saliva, Artificial | 1 | 2013 | 2 | 0.400 |
Why?
|
| alpha-Amylases | 1 | 2013 | 4 | 0.400 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 4 | 0.390 |
Why?
|
| Integrins | 1 | 2013 | 17 | 0.390 |
Why?
|
| Receptors, Opioid, delta | 1 | 2013 | 15 | 0.390 |
Why?
|
| Rats | 13 | 2014 | 1895 | 0.380 |
Why?
|
| Neuroblastoma | 4 | 2017 | 32 | 0.370 |
Why?
|
| Models, Molecular | 6 | 2019 | 204 | 0.370 |
Why?
|
| Nicotine | 1 | 2014 | 164 | 0.360 |
Why?
|
| Protein Kinases | 1 | 2012 | 34 | 0.360 |
Why?
|
| Pertussis Toxin | 6 | 2015 | 19 | 0.360 |
Why?
|
| Protein Conformation | 5 | 2017 | 110 | 0.340 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 112 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2010 | 89 | 0.310 |
Why?
|
| Time Factors | 6 | 2015 | 2205 | 0.300 |
Why?
|
| Protein Binding | 6 | 2019 | 244 | 0.300 |
Why?
|
| Ligands | 5 | 2011 | 90 | 0.290 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 2 | 2010 | 18 | 0.280 |
Why?
|
| Guanylate Cyclase | 2 | 2009 | 9 | 0.280 |
Why?
|
| Cyclic GMP | 2 | 2009 | 23 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2015 | 897 | 0.280 |
Why?
|
| Binding Sites | 4 | 2017 | 144 | 0.270 |
Why?
|
| Drama | 1 | 2007 | 1 | 0.260 |
Why?
|
| Dexamethasone | 1 | 2007 | 46 | 0.260 |
Why?
|
| RNA, Messenger | 6 | 2015 | 499 | 0.260 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 290 | 0.250 |
Why?
|
| Reactive Nitrogen Species | 1 | 2006 | 5 | 0.250 |
Why?
|
| Cannabis | 2 | 2023 | 30 | 0.240 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 121 | 0.240 |
Why?
|
| Brain Diseases | 1 | 2006 | 31 | 0.240 |
Why?
|
| Glucocorticoids | 1 | 2007 | 146 | 0.240 |
Why?
|
| Cell Membrane | 3 | 2016 | 109 | 0.240 |
Why?
|
| Health Education | 1 | 2007 | 149 | 0.240 |
Why?
|
| Cannabidiol | 2 | 2023 | 9 | 0.230 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2005 | 1 | 0.230 |
Why?
|
| Receptors, Eicosanoid | 1 | 2005 | 5 | 0.230 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 140 | 0.230 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 20 | 0.230 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 163 | 0.230 |
Why?
|
| Kinetics | 4 | 2013 | 250 | 0.230 |
Why?
|
| Terminology as Topic | 1 | 2005 | 68 | 0.220 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 252 | 0.220 |
Why?
|
| Macrophages | 1 | 2006 | 207 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 79 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2015 | 839 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 359 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.210 |
Why?
|
| RNA Interference | 2 | 2014 | 78 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Hallucinogens | 1 | 2023 | 13 | 0.200 |
Why?
|
| Calcium | 4 | 2015 | 339 | 0.190 |
Why?
|
| Protein Transport | 2 | 2016 | 80 | 0.190 |
Why?
|
| Rabbits | 3 | 2017 | 219 | 0.190 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2002 | 43 | 0.180 |
Why?
|
| Muscle Relaxation | 1 | 2002 | 21 | 0.180 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 55 | 0.180 |
Why?
|
| Protein Kinase C-alpha | 2 | 2015 | 15 | 0.180 |
Why?
|
| Aging | 3 | 2015 | 942 | 0.180 |
Why?
|
| Zinc | 1 | 2002 | 29 | 0.180 |
Why?
|
| Calcium Signaling | 2 | 2015 | 49 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Male | 13 | 2019 | 19441 | 0.160 |
Why?
|
| Schizophrenia | 1 | 2019 | 21 | 0.150 |
Why?
|
| Marijuana Abuse | 1 | 2019 | 18 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 65 | 0.150 |
Why?
|
| Reward | 1 | 2019 | 64 | 0.150 |
Why?
|
| Receptors, Opioid, mu | 2 | 2010 | 36 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2017 | 299 | 0.140 |
Why?
|
| Epilepsy | 1 | 2019 | 79 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 246 | 0.140 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 174 | 0.140 |
Why?
|
| Scintillation Counting | 1 | 2017 | 3 | 0.130 |
Why?
|
| Sulfur Radioisotopes | 1 | 2017 | 8 | 0.130 |
Why?
|
| Opioid Peptides | 2 | 2008 | 13 | 0.130 |
Why?
|
| Decision Making | 1 | 2019 | 189 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2017 | 32 | 0.130 |
Why?
|
| Phylogeny | 1 | 2017 | 67 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2010 | 41 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2016 | 36 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2016 | 13 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 179 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 170 | 0.120 |
Why?
|
| Cricetulus | 1 | 2016 | 21 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2007 | 193 | 0.120 |
Why?
|
| CHO Cells | 1 | 2016 | 29 | 0.120 |
Why?
|
| Calcium Channels | 2 | 2010 | 63 | 0.120 |
Why?
|
| Cricetinae | 1 | 2016 | 51 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 78 | 0.120 |
Why?
|
| Protein Structure, Secondary | 3 | 2019 | 59 | 0.120 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2015 | 2 | 0.110 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 4 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 9 | 0.110 |
Why?
|
| Ultrasonics | 1 | 2015 | 22 | 0.110 |
Why?
|
| Autoradiography | 1 | 2015 | 51 | 0.110 |
Why?
|
| Tyrosine | 1 | 2015 | 24 | 0.110 |
Why?
|
| Solitary Nucleus | 1 | 2015 | 34 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 37 | 0.110 |
Why?
|
| Hippocampus | 2 | 2015 | 216 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 43 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2014 | 14 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2014 | 62 | 0.110 |
Why?
|
| Genes, Immediate-Early | 1 | 2014 | 3 | 0.110 |
Why?
|
| Uterine Artery | 1 | 2014 | 5 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2014 | 74 | 0.110 |
Why?
|
| Baroreflex | 1 | 2015 | 86 | 0.110 |
Why?
|
| Superoxides | 1 | 2014 | 24 | 0.110 |
Why?
|
| Pregnancy, Animal | 1 | 2014 | 20 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 247 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 12 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2014 | 47 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2014 | 42 | 0.100 |
Why?
|
| Autoreceptors | 1 | 2014 | 9 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1224 | 0.100 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2013 | 5 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 96 | 0.100 |
Why?
|
| Wound Healing | 1 | 2015 | 185 | 0.100 |
Why?
|
| Amphetamine | 1 | 2014 | 43 | 0.100 |
Why?
|
| Thermodynamics | 2 | 2004 | 57 | 0.100 |
Why?
|
| Interleukin-1alpha | 1 | 2013 | 2 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 17 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2013 | 8 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2013 | 9 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2013 | 19 | 0.100 |
Why?
|
| Laminin | 1 | 2013 | 13 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2013 | 15 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 24 | 0.100 |
Why?
|
| Nucleus Accumbens | 2 | 2014 | 121 | 0.100 |
Why?
|
| Culture Media | 1 | 2013 | 48 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 4 | 0.100 |
Why?
|
| Fibronectins | 1 | 2013 | 39 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2013 | 49 | 0.100 |
Why?
|
| Urodynamics | 1 | 2013 | 88 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2014 | 241 | 0.100 |
Why?
|
| North Carolina | 2 | 2016 | 1300 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2015 | 393 | 0.090 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2014 | 147 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2014 | 255 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 87 | 0.090 |
Why?
|
| Muscle Contraction | 1 | 2013 | 175 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 152 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2013 | 224 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 46 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 215 | 0.090 |
Why?
|
| Dopamine | 1 | 2014 | 262 | 0.090 |
Why?
|
| Prosencephalon | 2 | 2012 | 8 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 145 | 0.080 |
Why?
|
| Hydrogen Bonding | 2 | 2017 | 18 | 0.080 |
Why?
|
| Sucrose | 1 | 2010 | 19 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 112 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2013 | 320 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2017 | 251 | 0.080 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2010 | 2 | 0.080 |
Why?
|
| Arrestins | 1 | 2010 | 3 | 0.080 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 7 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 1 | 2010 | 12 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 99 | 0.080 |
Why?
|
| Eating | 1 | 2010 | 77 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2009 | 18 | 0.070 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 14 | 0.070 |
Why?
|
| Receptors, Dopamine | 1 | 2008 | 26 | 0.070 |
Why?
|
| Neostriatum | 1 | 2008 | 28 | 0.070 |
Why?
|
| Adult | 3 | 2019 | 9259 | 0.070 |
Why?
|
| Leucine | 1 | 2007 | 23 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2007 | 66 | 0.070 |
Why?
|
| Cell Division | 1 | 2007 | 92 | 0.070 |
Why?
|
| Static Electricity | 1 | 2007 | 13 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 86 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 24 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 29 | 0.060 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2007 | 10 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 160 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 45 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2006 | 10 | 0.060 |
Why?
|
| Young Adult | 2 | 2019 | 2649 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 11 | 0.060 |
Why?
|
| Genomics | 1 | 2007 | 89 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2007 | 84 | 0.060 |
Why?
|
| Focus Groups | 1 | 2007 | 123 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 2007 | 59 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 132 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2007 | 96 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2007 | 171 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 127 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 87 | 0.060 |
Why?
|
| Microglia | 1 | 2006 | 67 | 0.060 |
Why?
|
| Adolescent | 2 | 2019 | 3519 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2007 | 193 | 0.060 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2005 | 18 | 0.060 |
Why?
|
| Mutation | 2 | 2012 | 497 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2006 | 243 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2004 | 11 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 717 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 316 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2013 | 454 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 854 | 0.050 |
Why?
|
| Research | 1 | 2004 | 81 | 0.050 |
Why?
|
| Female | 5 | 2019 | 19945 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 2 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 116 | 0.050 |
Why?
|
| Eicosanoids | 1 | 2002 | 9 | 0.050 |
Why?
|
| Nervous System | 1 | 2002 | 12 | 0.050 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2002 | 2 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 9 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2002 | 8 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 18 | 0.050 |
Why?
|
| Capsaicin | 1 | 2002 | 31 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 41 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 35 | 0.050 |
Why?
|
| Protons | 1 | 2002 | 22 | 0.050 |
Why?
|
| Zinc Compounds | 1 | 2002 | 4 | 0.050 |
Why?
|
| Chlorides | 1 | 2002 | 13 | 0.050 |
Why?
|
| Magnesium | 1 | 2002 | 29 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 60 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 164 | 0.040 |
Why?
|
| Aorta | 1 | 2002 | 125 | 0.040 |
Why?
|
| Software | 1 | 2002 | 124 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 264 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 155 | 0.040 |
Why?
|
| Receptors, Dopamine D3 | 2 | 2014 | 33 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 792 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 461 | 0.040 |
Why?
|
| Resorcinols | 2 | 2013 | 7 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2015 | 861 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 70 | 0.040 |
Why?
|
| Algorithms | 1 | 2002 | 536 | 0.040 |
Why?
|
| Child | 1 | 2023 | 2435 | 0.030 |
Why?
|
| Clathrin | 1 | 2016 | 3 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Endosomes | 1 | 2016 | 13 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 33 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 39 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2015 | 35 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cerebellum | 1 | 2015 | 25 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 98 | 0.030 |
Why?
|
| Monoglycerides | 1 | 2014 | 2 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 4 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 41 | 0.030 |
Why?
|
| Carbamates | 1 | 2014 | 16 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 47 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 60 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2013 | 58 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 2013 | 7 | 0.030 |
Why?
|
| Carbachol | 1 | 2013 | 17 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2013 | 3 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 65 | 0.020 |
Why?
|
| Spatial Behavior | 1 | 2013 | 11 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 8 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2013 | 17 | 0.020 |
Why?
|
| Glycine | 1 | 2013 | 26 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2013 | 100 | 0.020 |
Why?
|
| Heart Rate | 1 | 2015 | 362 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 10263 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2013 | 135 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 39 | 0.020 |
Why?
|
| Self Administration | 1 | 2014 | 382 | 0.020 |
Why?
|
| Lipoylation | 1 | 2012 | 4 | 0.020 |
Why?
|
| Learning | 1 | 2013 | 84 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 11851 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1179 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 961 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 492 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2010 | 8 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1083 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 154 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 138 | 0.020 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2007 | 5 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 34 | 0.020 |
Why?
|
| Benzofurans | 1 | 2007 | 3 | 0.020 |
Why?
|
| Chromones | 1 | 2007 | 6 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2007 | 17 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2007 | 18 | 0.020 |
Why?
|
| Gadolinium | 1 | 2007 | 18 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 173 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 74 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 90 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 204 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 120 | 0.020 |
Why?
|
| Analgesics | 1 | 2007 | 111 | 0.020 |
Why?
|
| Dynorphins | 1 | 2006 | 8 | 0.020 |
Why?
|
| Enkephalins | 1 | 2006 | 11 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 1111 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2006 | 24 | 0.020 |
Why?
|